Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunoglobulin Replacement Therapy for Immunoglobulin G Subclass 2 Deficient Patients With Bronchiectasis- A Proof of Concept Study

NCT03737617 is registered in ClinicalTrials.gov with University of Edinburgh as lead sponsor.

NCT NCT03737617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03737617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunoglobulin Replacement Therapy for Immunoglobulin G Subclass 2 Deficient Patients With Bronchiectasis- A Proof of Concept Study
Lead sponsor
University of Edinburgh
Phase
Phase 4
Overall status
Withdrawn
Start date
August 5, 2022
Completion date
December 1, 2024
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bronchiectasis, immunoglobulin subclass deficiency